Adage Capital Partners Gp, L.L.C. Pro Qr Therapeutics N.V. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.6 Billion
Q3 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 3,625,467 shares of PRQR stock, worth $13.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,625,467

Previous 3,625,467 -0.0%

Holding current value

$13.3 Million

Previous $6.02 Million 9.64%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.8 - $3.7 $260,373 - $1.2 Million	325,467 Added 9.86%	3,625,467 $13.4 Million
Q1 2022 May 16, 2022	SELL	$0.9 - $8.39 $1.27 Million - $11.9 Million	-1,415,152 Reduced 30.01%	3,300,000 $2.99 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $106,744 - $175,218	20,687 Added 0.44%	4,715,152 $39.5 Million
Q1 2021 May 17, 2021	BUY	$4.14 - $9.22 $597,828 - $1.33 Million	144,403 Added 3.17%	4,694,465 $31 Million
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $111,599 - $210,444	-21,257 Reduced 0.47%	4,550,062 $25 Million
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $4.88 Million - $8.78 Million	835,812 Added 22.37%	4,571,319 $45.3 Million
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $4.17 Million - $6.13 Million	273,566 Added 7.9%	3,735,507 $58.9 Million
Q3 2018 Nov 14, 2018	BUY	$6.45 - $21.6 $8.38 Million - $28.1 Million	1,299,414 Added 60.09%	3,461,941 $67 Million
Q2 2018 Aug 14, 2018	BUY	$2.95 - $7.45 $1.95 Million - $4.94 Million	662,527 Added 44.17%	2,162,527 $15.8 Million
Q1 2018 May 15, 2018	BUY	$2.9 - $3.5 $1.45 Million - $1.75 Million	500,000 Added 50.0%	1,500,000 $4.61 Million
Q4 2017 Feb 14, 2018	BUY	$2.8 - $4.8 $2.8 Million - $4.8 Million	1,000,000	1,000,000 $3.23 Million

Others Institutions Holding PRQR

# of Institutions

Shares Held

17.4M

Call Options Held

37.7K

Put Options Held

21.3K

View Full List

About ProQR Therapeutics N.V.

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $262M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

More about PRQR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Pro Qr Therapeutics N.V. Transaction History